BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28583899)

  • 1. Statins do not inhibit the FGFR signaling in chondrocytes.
    Fafilek B; Hampl M; Ricankova N; Vesela I; Balek L; Kunova Bosakova M; Gudernova I; Varecha M; Buchtova M; Krejci P
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1522-1530. PubMed ID: 28583899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor and canonical WNT/β-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage.
    Buchtova M; Oralova V; Aklian A; Masek J; Vesela I; Ouyang Z; Obadalova T; Konecna Z; Spoustova T; Pospisilova T; Matula P; Varecha M; Balek L; Gudernova I; Jelinkova I; Duran I; Cervenkova I; Murakami S; Kozubik A; Dvorak P; Bryja V; Krejci P
    Biochim Biophys Acta; 2015 May; 1852(5):839-50. PubMed ID: 25558817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia.
    Matsushita M; Kitoh H; Ohkawara B; Mishima K; Kaneko H; Ito M; Masuda A; Ishiguro N; Ohno K
    PLoS One; 2013; 8(12):e81569. PubMed ID: 24324705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3.
    Balek L; Gudernova I; Vesela I; Hampl M; Oralova V; Kunova Bosakova M; Varecha M; Nemec P; Hall T; Abbadessa G; Hatch N; Buchtova M; Krejci P
    Bone; 2017 Dec; 105():57-66. PubMed ID: 28826843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation.
    Correa D; Somoza RA; Lin P; Greenberg S; Rom E; Duesler L; Welter JF; Yayon A; Caplan AI
    Osteoarthritis Cartilage; 2015 Mar; 23(3):443-53. PubMed ID: 25464167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia.
    Martin L; Kaci N; Estibals V; Goudin N; Garfa-Traore M; Benoist-Lasselin C; Dambroise E; Legeai-Mallet L
    Hum Mol Genet; 2018 Jan; 27(1):1-13. PubMed ID: 29040558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
    Jonquoy A; Mugniery E; Benoist-Lasselin C; Kaci N; Le Corre L; Barbault F; Girard AL; Le Merrer Y; Busca P; Schibler L; Munnich A; Legeai-Mallet L
    Hum Mol Genet; 2012 Feb; 21(4):841-51. PubMed ID: 22072392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis.
    Davidson D; Blanc A; Filion D; Wang H; Plut P; Pfeffer G; Buschmann MD; Henderson JE
    J Biol Chem; 2005 May; 280(21):20509-15. PubMed ID: 15781473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal of patient-specific growth plate cartilage xenograft model for FGFR3 chondrodysplasia.
    Kimura T; Ozaki T; Fujita K; Yamashita A; Morioka M; Ozono K; Tsumaki N
    Osteoarthritis Cartilage; 2018 Nov; 26(11):1551-1561. PubMed ID: 30086379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
    Ozasa A; Komatsu Y; Yasoda A; Miura M; Sakuma Y; Nakatsuru Y; Arai H; Itoh N; Nakao K
    Bone; 2005 Jun; 36(6):1056-64. PubMed ID: 15869918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of fibroblast growth factor receptor 3 by fibroblast growth factor 2 in cultured chick embryo chondrocytes.
    Suh JY; Kim YS; Park JW; Sonn JK; Kim WT
    Cell Biol Int; 2005 Mar; 29(3):203-12. PubMed ID: 15878293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossification.
    Weizmann S; Tong A; Reich A; Genina O; Yayon A; Monsonego-Ornan E
    Matrix Biol; 2005 Dec; 24(8):520-9. PubMed ID: 16253490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast Growth Factor Receptor 3 Inhibits Osteoarthritis Progression in the Knee Joints of Adult Mice.
    Tang J; Su N; Zhou S; Xie Y; Huang J; Wen X; Wang Z; Wang Q; Xu W; Du X; Chen H; Chen L
    Arthritis Rheumatol; 2016 Oct; 68(10):2432-43. PubMed ID: 27159076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormones regulate fibroblast growth factor receptor signaling during chondrogenesis.
    Barnard JC; Williams AJ; Rabier B; Chassande O; Samarut J; Cheng SY; Bassett JH; Williams GR
    Endocrinology; 2005 Dec; 146(12):5568-80. PubMed ID: 16150908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype.
    Murakami S; Balmes G; McKinney S; Zhang Z; Givol D; de Crombrugghe B
    Genes Dev; 2004 Feb; 18(3):290-305. PubMed ID: 14871928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice.
    Kimura T; Bosakova M; Nonaka Y; Hruba E; Yasuda K; Futakawa S; Kubota T; Fafilek B; Gregor T; Abraham SP; Gomolkova R; Belaskova S; Pesl M; Csukasi F; Duran I; Fujiwara M; Kavkova M; Zikmund T; Kaiser J; Buchtova M; Krakow D; Nakamura Y; Ozono K; Krejci P
    Sci Transl Med; 2021 May; 13(592):. PubMed ID: 33952673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressing UPR-dependent overactivation of FGFR3 signaling ameliorates SLC26A2-deficient chondrodysplasias.
    Zheng C; Lin X; Xu X; Wang C; Zhou J; Gao B; Fan J; Lu W; Hu Y; Jie Q; Luo Z; Yang L
    EBioMedicine; 2019 Feb; 40():695-709. PubMed ID: 30685387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF8 and FGFR3 are up-regulated in hypertrophic chondrocytes: Association with chondrocyte death in deep zone of Kashin-Beck disease.
    Liu H; Fang Q; Wang M; Wang W; Zhang M; Zhang D; He Y; Zhang Y; Wang H; Otero M; Ma T; Chen J
    Biochem Biophys Res Commun; 2018 Jun; 500(2):184-190. PubMed ID: 29626475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR3 induces degradation of BMP type I receptor to regulate skeletal development.
    Qi H; Jin M; Duan Y; Du X; Zhang Y; Ren F; Wang Y; Tian Q; Wang X; Wang Q; Zhu Y; Xie Y; Liu C; Cao X; Mishina Y; Chen D; Deng CX; Chang Z; Chen L
    Biochim Biophys Acta; 2014 Jul; 1843(7):1237-47. PubMed ID: 24657641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insight on FGFR3-related chondrodysplasias molecular physiopathology revealed by human chondrocyte gene expression profiling.
    Schibler L; Gibbs L; Benoist-Lasselin C; Decraene C; Martinovic J; Loget P; Delezoide AL; Gonzales M; Munnich A; Jais JP; Legeai-Mallet L
    PLoS One; 2009 Oct; 4(10):e7633. PubMed ID: 19898608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.